• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Leading “Not So Different” Podcast Episodes of 2020


Here are some of our most-listened-to 2020 "Not So Different" podcasts.

Hi, I’m Skylar Jeremias for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are some of our most-listened-to 2020 "Not So Different" podcasts.

Anurag Rathore, PhD, coordinator of the Center of Excellence for Biopharmaceutical Technology in Delhi, India, discusses findings from his study on biosimilar application failures.

Ryan Haumschild, PharmD, director of pharmacy at Emory Healthcare in Atlanta, Georgia, explains how a series of steps helped to increase biosimilar utilization within the Emory system and how these initiatives could be implemented on a larger scale.

Ha Kung Wong, an intellectual property law attorney and partner at Venable Fitzpatrick in New York, New York, and April Breyer Menon, an expert on biosimilar patent law and founder of April Breyer Consulting in Chicago, Illinois, discuss potential bills to improve biosimilar uptake and their chances for passage.

Christine Simmon, executive director of the Biosimilars Council and senior vice president of policy and strategic alliances at the Association for Accessible Medicines (AAM) in Washington, DC, discusses some of the advocacy changes the organization is looking to advance and their chances of approval.

Lastly, we spoke with Adrian van den Hoven, director general of Medicines for Europe, and Diogo Piedade, market access manager for Medicines for Europe, about their scorecard report for biosimilar access and what European markets they feel need the most work.

To read all these articles and more, visit centerforbiosimilars.com.

Related Content
© 2024 MJH Life Sciences

All rights reserved.